Lv31
390 积分 2025-07-28 加入
Understanding the therapeutic toolkit for inflammatory bowel disease
4天前
已完结
Therapeutic Inhibition of the JAK-STAT pathway in the treatment of Inflammatory Bowel Disease
10天前
已完结
The impact of vedolizumab therapy on extraintestinal manifestations in patients with inflammatory bowel disease: A systematic review and meta‐analysis
11天前
已完结
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease
13天前
已完结
Natural History, Treatment Persistence and Predictors of Treatment Failure in Patients With Ulcerative Colitis on 5-Aminosalicylic Acid: A US Population-Level Cohort Study
17天前
已完结
Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel disease
22天前
已完结
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
1个月前
已完结
P274 Close monitoring of CRP and fecal calprotectin levels to predict relapse in Crohn's disease patients. A sub-analysis of the STORI study
1个月前
已关闭
Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?
1个月前
已完结
The long journey of salicylates in ulcerative colitis: The past and the future
1个月前
已完结
皖公网安备34019202002308
